FGFR2 Fusions
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| derazantinib | ARQULE INC (ARQL) |
Frequently asked questions
How many drugs are in development for FGFR2 Fusions?
BioSniper tracks 1 drug in development for FGFR2 Fusions across 1 company.
How many clinical trials target FGFR2 Fusions?
There are 1 clinical trial targeting FGFR2 Fusions tracked by BioSniper.
Deep-dive into FGFR2 Fusions
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis